Bellevue Group AG - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 50 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$39,000
-13.3%
3,3330.0%0.01%0.0%
Q3 2016$45,000
-31.8%
3,3330.0%0.01%
-33.3%
Q2 2016$66,000
+17.9%
3,3330.0%0.01%
+20.0%
Q1 2016$56,0003,3330.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Simplify Asset Management Inc. 2,700,000$823,5000.09%
683 Capital Management, LLC 2,650,000$808,2500.06%
GSA CAPITAL PARTNERS LLP 355,867$1090.01%
RBF Capital, LLC 391,265$119,3360.01%
UBS OCONNOR LLC 393,975$120,1620.00%
XTX Topco Ltd 15,597$4,7570.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 106,700$32,5440.00%
AMERIPRISE FINANCIAL INC 8,592,471$2,620,7040.00%
DRW Securities, LLC 120,365$370.00%
DFPG INVESTMENTS, LLC 32,430$10,8960.00%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders